Bryce Olson orchestrated his own treatment by assembling a team of scientists, requesting to have his genome sequenced and seeking out targeted therapies. READ this informative article from Forbes contributor Zina Moukheiber who regularly covers biotech, and learn how genomic sequencing data can empower patients and help them open up new doors into clinical trials, access new collaborations with researchers, and get exposure to cutting-edge insights that simply aren’t available to patients that follow only the standard of care.